Biofarm Statistics

Total Valuation

Biofarm has a market cap or net worth of RON 703.55 million. The enterprise value is 555.56 million.

Market Cap	703.55M
Enterprise Value	555.56M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	Aug 18, 2025

Share Statistics

Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	985.37M
Shares Outstanding	985.37M
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	-28.70%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	88.33%
Float	477.14M

Valuation Ratios

The trailing PE ratio is 8.99.

PE Ratio	8.99
Forward PE	n/a
PS Ratio	2.27
PB Ratio	1.38
P/TBV Ratio	1.38
P/FCF Ratio	11.15
P/OCF Ratio	8.90
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.09, with an EV/FCF ratio of 8.80.

EV / Earnings	6.45
EV / Sales	1.79
EV / EBITDA	5.09
EV / EBIT	6.04
EV / FCF	8.80

Financial Position

The company has a current ratio of 4.67, with a Debt / Equity ratio of 0.00.

Current Ratio	4.67
Quick Ratio	4.06
Debt / Equity	0.00
Debt / EBITDA	0.01
Debt / FCF	0.02
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 17.83% and return on invested capital (ROIC) is 11.89%.

Return on Equity (ROE)	17.83%
Return on Assets (ROA)	10.48%
Return on Invested Capital (ROIC)	11.89%
Return on Capital Employed (ROCE)	17.96%
Revenue Per Employee	850,213
Profits Per Employee	235,899
Employee Count	373
Asset Turnover	0.57
Inventory Turnover	1.05

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.57% in the last 52 weeks. The beta is 0.31, so Biofarm's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-7.57%
50-Day Moving Average	0.68
200-Day Moving Average	0.73
Relative Strength Index (RSI)	62.42
Average Volume (20 Days)	86,219

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Biofarm had revenue of RON 310.33 million and earned 86.10 million in profits. Earnings per share was 0.08.

Revenue	310.33M
Gross Profit	257.94M
Operating Income	92.01M
Pretax Income	98.23M
Net Income	86.10M
EBITDA	109.15M
EBIT	92.01M
Earnings Per Share (EPS)	0.08

Full Income Statement

Balance Sheet

The company has 149.00 million in cash and 1.01 million in debt, giving a net cash position of 147.99 million or 0.15 per share.

Cash & Cash Equivalents	149.00M
Total Debt	1.01M
Net Cash	147.99M
Net Cash Per Share	0.15
Equity (Book Value)	510.59M
Book Value Per Share	0.52
Working Capital	283.43M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 79.06 million and capital expenditures -15.96 million, giving a free cash flow of 63.10 million.

Operating Cash Flow	79.06M
Capital Expenditures	-15.96M
Free Cash Flow	63.10M
FCF Per Share	0.06

Full Cash Flow Statement

Margins

Gross margin is 83.12%, with operating and profit margins of 29.65% and 27.75%.

Gross Margin	83.12%
Operating Margin	29.65%
Pretax Margin	31.66%
Profit Margin	27.75%
EBITDA Margin	35.17%
EBIT Margin	29.65%
FCF Margin	20.33%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 4.38%.

Dividend Per Share	0.03
Dividend Yield	4.38%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	3
Payout Ratio	33.90%
Buyback Yield	-0.41%
Shareholder Yield	3.97%
Earnings Yield	12.24%
FCF Yield	8.97%

Dividend Details

Stock Splits

The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.

Last Split Date	Apr 30, 2008
Split Type	Forward
Split Ratio	1.12001

Scores

Biofarm has an Altman Z-Score of 8.28.

Altman Z-Score	8.28
Piotroski F-Score	n/a